alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.1

Certification Pursuant
to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes -Oxley Act
of 2002

In
connection with the annual report of China Housing & Land Development, Inc. (the
Company), on Form 10-K for the period ended December 31, 2007 as filed with the Securities
and Exchange Commission (SEC) on the date hereof (the Report), the undersigned officer of
the Company certifies, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:

i.       
          the Report fully complies with the requirements of Section 13(a)or 15(d) of the
          Securities Exchange Act of 1934; and

ii.       
          the information contained in the Report fairly presents, in all material
          respects, the financial condition and results of operations of the Company.

A
signed original of this written statement has been provided to the Company and will be
retained by the Company and will be furnished to the SEC or our staff upon request.

/s/ Lu PingjiLu Pingji Chairman and
Chief Executive Officer March 28, 2008

This
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002 is not filed for purposes of Section 18 of the Securities Exchange Act of
1934 but is instead furnished as provided by applicable rules of the Securities Exchange
Commission.

---
# Official Journal C 187/22 J

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 187 |
| | |
| English edition | Information and Notices | Volume 4722 July 2004 |

ISSN 1725-2423

Official Journal

of the European Union

C 187

English edition

Information and Notices

Volume 4722 July 2004

---

| Notice No | Contents | page |
| --- | --- | --- |
| | Acts adopted under Title VI of the Treaty on European Union |
| 2004/C 187/1 | Draft Budget 2005 | 1 |

Notice No

Contents

page

Acts adopted under Title VI of the Treaty on European Union

2004/C 187/1

Draft Budget 2005

1

---

| | I   Information |
| --- | --- |
| | Commission |
| 2004/C 187/2 | Euro exchange rates | 10 |
| 2004/C 187/3 | Notice to importers in the European Union in 2005 of controlled substances that deplete the ozone layer, regarding Regulation (EC) No 2037/2000 of the European Parliament and of the Council on substances that deplete the ozone layer | 11 |
| 2004/C 187/4 | Notice to exporters of controlled substances that may deplete the ozone layer in the European Union in 2005 regarding Regulation (EC) No 2037/2000 of the European Parliament and of the Council on ‘Substances that deplete the ozone layer’ | 18 |
| 2004/C 187/5 | Notice to users of controlled substances in the European Union allowed for essential uses in the Community in 2005 pursuant to Regulation (EC) No 2037/2000 of the European Parliament and of the Council on substances that deplete the ozone layer | 24 |
| 2004/C 187/6 | Prior notification of a concentration (Case No COMP/M.3493 — YAMANOUCHI/FUJISAWA) (1) | 28 |

I   Information

Commission

2004/C 187/2

Euro exchange rates

10

2004/C 187/3

Notice to importers in the European Union in 2005 of controlled substances that deplete the ozone layer, regarding Regulation (EC) No 2037/2000 of the European Parliament and of the Council on substances that deplete the ozone layer

11

2004/C 187/4

Notice to exporters of controlled substances that may deplete the ozone layer in the European Union in 2005 regarding Regulation (EC) No 2037/2000 of the European Parliament and of the Council on ‘Substances that deplete the ozone layer’

18

2004/C 187/5

Notice to users of controlled substances in the European Union allowed for essential uses in the Community in 2005 pursuant to Regulation (EC) No 2037/2000 of the European Parliament and of the Council on substances that deplete the ozone layer

24

2004/C 187/6

Prior notification of a concentration (Case No COMP/M.3493 — YAMANOUCHI/FUJISAWA) (1)

28

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2594 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2594

 To extend and modify the temporary reduction of duty on Thiamethoxam.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

 Mr. Carper (for himself and Mr. Coons) introduced the following bill; 
     which was read twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To extend and modify the temporary reduction of duty on Thiamethoxam.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. THIAMETHOXAM.

    (a) In General.--Heading 9902.03.11 of the Harmonized Tariff 
Schedule of the United States (relating to Thiamethoxam) is amended--
            (1) by striking ``5%'' in the column 1 general rate of duty 
        column and inserting ``5.9%''; and
            (2) by striking the date in the effective period column and 
        inserting ``12/31/2015''.
    (b) Effective Date.--The amendments made by subsection (a) apply 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
chd-ex1021_224.htm



EXHIBIT 10.21

 




 

September 4, 2021


	
 
	
To:
	
Barry Bruno
	
 





	
 
	
From:
	
Matthew Farrell
	
 





	
 
	
CC:
	
Rene Hemsey
	
 




 

 

Confirmation of Promotion effective dated 10/01/2021

 

Congratulations!

 

I am thrilled to offer you the position of Executive Vice President, Chief Marketing Officer as of October  1, 2021.

 

Base Salary - $475,000 

Bonus Target – 50%

Bonus Target $ $237,500

Total Compensation at Target - $712,500

Stock Option Target – 115% 

Stock Option Target $* $546,250

Total Remuneration at Target - $1,258,750

Salary Grade - US Grade Elected Officer

 

You will receive a stock option grant on October 1, 2021 in the amount of $150,000*. Thereafter, grants  will occur beginning in June 2022.

 


					
	
 
	
Current
	
New
	
$ Change
	
% Change

	
Base Salary
	
$453,000
	
$475,000
	
$22,000
	
5%

	
Bonus Target %

Bonus Target $
	
50%

$226,500
	
50%

$237,500
	
 

$11,000
	
 

	
Total Compensation at Target
	
$679,500
	
$712,500
	
$33,000
	
5%

	
Stock Option Target % Stock Option Plan $*
	
93%

$421,290
	
115%

$546,250
	
 

124,960
	
 

	
Total Remuneration at Target
	
$1,100,790
	
$1,258,750
	
$157,960
	
14%




 

I look forward to seeing the continued impact you will have on our business.

 

Sincerely,

 

Matthew Farrell

 

*Stock Option grant amounts represent the grant date fair value of the award.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS OF CITADEL TECHNOLOGY, INC. FOR THE THREE
MONTHS ENDED MAY 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
CONSOLIDATED FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          FEB-28-2000
<PERIOD-START>                             MAR-01-1999
<PERIOD-END>                               MAY-31-1999
<CASH>                                       7,635,010
<SECURITIES>                                         0
<RECEIVABLES>                                5,906,491
<ALLOWANCES>                                 1,275,000
<INVENTORY>                                    146,764
<CURRENT-ASSETS>                            16,071,930
<PP&E>                                       2,178,869
<DEPRECIATION>                               1,060,169
<TOTAL-ASSETS>                              33,760,156
<CURRENT-LIABILITIES>                       10,753,415
<BONDS>                                        204,501
<PREFERRED-MANDATORY>                               21
<PREFERRED>                                          0
<COMMON>                                       451,420
<OTHER-SE>                                  12,872,174
<TOTAL-LIABILITY-AND-EQUITY>                33,760,156
<SALES>                                      1,592,485
<TOTAL-REVENUES>                             1,592,485
<CGS>                                          937,918
<TOTAL-COSTS>                                  937,918
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              11,478
<INCOME-PRETAX>                            (1,882,869)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,882,869)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,882,869)
<EPS-BASIC>                                      (.05)
<EPS-DILUTED>                                    (.05)


</TABLE>
Christinia THERIEN, Appellant, v. Michael LAURATO and Karina Jaugregui, Appellees.

Case No. 2D16-2373

District Court of Appeal of Florida, Second District.

Opinion filed December 13, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
Registrant is a limited partnership which invests in real estate, and
real estate joint ventures.  In accordance with industry practice, its
balance sheet is unclassified.  For full information, refer to the
accompanying unaudited financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          OCT-31-1999
<PERIOD-END>                               JUL-31-1999
<CASH>                                         799,915
<SECURITIES>                                         0
<RECEIVABLES>                                  220,343
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               3,414,335<F1>
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   3,244,057<F2>
<TOTAL-LIABILITY-AND-EQUITY>                 3,414,335<F3>
<SALES>                                              0
<TOTAL-REVENUES>                             5,013,482<F4>
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               512,010
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              4,501,472
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          4,501,472
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 4,501,472
<EPS-BASIC>                                    25.25<F5>
<EPS-DILUTED>                                        0
<FN>
<F1>In addition to cash and receivables, total asset include investment
in joint venture of $2,338,299 and other assets of $55,778.
<F2>Other Stockholders' Equity represents partners' capital.
<F3>Liabilities include accounts payable and other liabilities of $170,278.
<F4>Total revenue includes rent of $551,241 gains on sales of real estate
of $3,994,134, equity in earnings of joint venture of $197,394 and
interest and other revenues of $270,713.
<F5>Represents net income per Unit of limited partnership interest.
</FN>


</TABLE>
[Federal Register Volume 74, Number 71 (Wednesday, April 15, 2009)]
[Notices]
[Page 17470]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-8560]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 13368-000]


Blue Heron Hydro, LLC; Notice of Preliminary Permit Applications 
Accepted for Filing and Soliciting Comment, Motions To Intervene, and 
Competing Applications

April 8, 2009.
    On February 6, 2009, Blue Heron Hydro, LLC, filed an application, 
pursuant to section 4(f) of the Federal Power Act, proposing to study 
the feasibility of the Townsend Dam Hydroelectric Project, to be 
located on the West River, in Windham County, Vermont.
    The proposed Townsend Dam Hydroelectric Project would be located 
at: (1) The existing 1,700-foot-long U.S. Army Corps of Engineers 
Townsend Dam; (2) an existing Corps intake tower and control works, and 
(3) an existing 735-acre reservoir with 32,800 acre-feet of storage.
    The project would consist of: (1) Six new turbine generating units 
connected to the intake tower with a total installed capacity of 0.96 
megawatts; (2) a new 1-mile-long, 45 kilovolt, 3 phase transmission 
line and transformer connected to an existing above ground distribution 
system; and (3) appurtenant facilities. The Townsend Dam Project would 
have an estimated average annual generation of 3,605 megawatt-hours, 
which would be sold to local utilities.
    Applicant Contact: Ms. Lori Barg, Blue Heron Hydro, LLC, 113 
Bartlett Rd., Plainfield, VT 05667, phone (802) 454-1874.
    FERC Contact: John Ramer, (202) 502-8969.
    Deadline for filing comments, motions to intervene, competing 
applications (without notices of intent), or notices of intent to file 
competing applications: 60 days from the issuance of this notice. 
Comments, motions to intervene, notices of intent, and competing 
applications may be filed electronically via the Internet. See 18 CFR 
385.2001(a)(1)(iii) and the instructions on the Commission's Web site 
under the ``e-Filing'' link. If unable to be filed electronically, 
documents may be paper-filed. To paper-file, an original and eight 
copies should be mailed to: Kimberly D. Bose, Secretary, Federal Energy 
Regulatory Commission, 888 First Street, NE., Washington, DC 20426. For 
more information on how to submit these types of filings please go to 
the Commission's Web site located at http://www.ferc.gov/filing-comments.asp. More information about this project can be viewed or 
printed on the ``eLibrary'' link of Commission's Web site at http://www.ferc.gov/docs-filing/elibrary.asp. Enter the docket number (P-
13368) in the docket number field to access the document. For 
assistance, call toll-free 1-866-208-3372.

Kimberly D. Bose,
Secretary.
 [FR Doc. E9-8560 Filed 4-14-09; 8:45 am]
BILLING CODE 6717-01-P
STATE of Louisiana v. Peter E. HALEY

NO. 2017-KO-1230

Supreme Court of Louisiana.

April 27, 2018

Denied.

HUGHES, J., would grant in part.
Gregory J. PERRIERA v. LOUISIANA DEPARTMENT OF PUBLIC SAFETY AND CORRECTIONS

NO. 2018-CI-0496

Supreme Court of Louisiana.

May 11, 2018

WRIT NOT CONSIDERED. Petitioner has not demonstrated that he sought review in the court(s) below before filing in this Court nor shown the "extraordinary circumstances" that would justify bypassing that level of review. La.S.Ct.R. X § 5(b).
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED CONDENSED BALANCE SHEETS AT SEPTEMBER 1, 1996, THE CONSOLIDATED
CONDENSED INCOME STATEMENTS, THE CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOW
AND THE RELATED NOTES, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-01-1996
<PERIOD-START>                             DEC-04-1995
<PERIOD-END>                               SEP-01-1996
<CASH>                                          28,269
<SECURITIES>                                       104
<RECEIVABLES>                                  101,434
<ALLOWANCES>                                    (4,064)
<INVENTORY>                                     46,620
<CURRENT-ASSETS>                               193,053
<PP&E>                                          50,746
<DEPRECIATION>                                 (74,499)
<TOTAL-ASSETS>                                 329,020
<CURRENT-LIABILITIES>                          103,176
<BONDS>                                         25,506
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           189
<OTHER-SE>                                     193,422
<TOTAL-LIABILITY-AND-EQUITY>                   329,020
<SALES>                                        295,745
<TOTAL-REVENUES>                               295,745
<CGS>                                          177,532
<TOTAL-COSTS>                                  256,262
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,015
<INCOME-PRETAX>                                 40,498
<INCOME-TAX>                                    13,771
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    26,727
<EPS-PRIMARY>                                     1.63
<EPS-DILUTED>                                     1.62
        

</TABLE>
----

(2004/C 70 E/136)

WRITTEN QUESTION E-2734/03

by Glyn Ford (PSE) to the Commission

(11 September 2003)

Subject:   Encryption of EU communications

In light of the report on echelon that recommended the Commission encrypt its communications, can the Commission inform us of the progress made in ensuring the encryption of its communications especially for overseas offices?

Answer given by Mr Kinnock on behalf of the Commission

(4 November 2003)

The Commission has taken all necessary steps to ensure that the security features of its communications are developed in order to deal with the risks properly identified by the report on Echelon.

The Commission is working in close co-operation with competent authorities from Member States on the choice of systems. The Honourable Member will understand that, for security reasons, the Commission is unable to communicate any further details in the context of a Parliamentary question. However, the Commission offers to inform the Honourable Member more comprehensively if he wishes to make direct contact with the relevant Service.

----
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2627 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2627

  To extend and modify the temporary reduction of duty on fludioxonil.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

 Mr. Nelson of Nebraska introduced the following bill; which was read 
             twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
  To extend and modify the temporary reduction of duty on fludioxonil.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. FLUDIOXONIL.

    (a) In General.--Heading 9902.12.54 of the Harmonized Tariff 
Schedule of the United States (relating to fludioxonil) is amended--
            (1) by striking ``1.0%'' in the column 1 general rate of 
        duty column and inserting ``5.7%''; and
            (2) by striking the date in the effective period column and 
        inserting ``12/31/2015''.
    (b) Effective Date.--The amendments made by subsection (a) apply to 
goods entered, or withdrawn from warehouse for consumption, on or after 
the 15th day after the date of the enactment of this Act.
                                 <all>
```
##### 



EXHIBIT 12.1
 LIFEPOINT HOSPITALS, INC.
COMPUTATIONS OF RATIOS OF EARNINGS TO FIXED CHARGES
(Unaudited)
(Dollars in Millions)
 Years Ended December 31,2003
    
    
    2004
    
    
    2005
    
    
    2006
    
    
    2007EARNINGSIncome from continuing operations before minority interests and income taxes
    
    $
    115.4
    
    
    $
    142.2
    
    
    $
    143.2
    
    
    $
    239.7
    
    
    $
    212.4Fixed charges, exclusive of capitalized interest
    
    
    17.2
    
    
    
    17.2
    
    
    
    71.5
    
    
    
    119.0
    
    
    
    111.8TOTAL EARNINGS
    
    $
    132.6
    
    
    $
    159.4
    
    
    $
    214.7
    
    
    $
    358.7
    
    
    $
    324.2FIXED CHARGESInterest charged to expense(a)
    
    $
    14.4
    
    
    $
    14.0
    
    
    $
    65.6
    
    
    $
    111.0
    
    
    $
    102.8Interest portion of rental expense
    
    
    2.8
    
    
    
    3.2
    
    
    
    5.9
    
    
    
    8.0
    
    
    
    9.0Fixed charges, exclusive of capitalized interest
    
    
    17.2
    
    
    
    17.2
    
    
    
    71.5
    
    
    
    119.0
    
    
    
    111.8Capitalized interest
    
    
    0.8
    
    
    
    1.1
    
    
    
    3.0
    
    
    
    1.2
    
    
    
    1.7TOTAL FIXED CHARGES
    
    $
    18.0
    
    
    $
    18.3
    
    
    $
    74.5
    
    
    $
    120.2
    
    
    $
    113.5RATIO OF EARNINGS TO FIXED CHARGES
    
    
    7.37
    
    
    
    8.71
    
    
    
    2.88
    
    
    
    2.98
    
    
    
    2.86
 
 (a)
    
    excluding interest income